共 50 条
- [31] Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1199 - 1207
- [33] Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (11): : 1455 - 1460
- [34] The 9-month results of the TROPICAL study: A multicenter nonrandomized study of the cypher sirolimus-eluting stent in the treatment of patients with an in-stent restenotic native coronary artery lesion. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 55E - 55E
- [35] SPIRIT II clinical study:: A clinical evaluation of the XIENCEI™ v Everolimus Eluting Coronary Stent System in the treatment of patients with de novo, native coronary artery lesions -: IVUS substudy AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 145M - 145M